SCHEMBL31323585

SCHEMBL31323585

O=C1CCC(Cc2ccc(C3CCNCC3)cc2)C(=O)N1

nearest known ligand 0.62

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 17/20 0.62
▸ DDB1 Q16531 6/20 0.62
▸ HTT P42858 1/20 0.56
▸ GAA P10253 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25843790 0.87 CRBN (0.64) CRBNDDB1HTTGAAPOLB
SCHEMBL25843794 0.83 HTT (0.60) CRBNDDB1HTTGAAPOLB
SCHEMBL25843897 0.82 CRBN (0.57) CRBNDDB1HTTGAAPOLB
SCHEMBL26329288 0.81 HTT (0.57) CRBNDDB1HTTGAAPOLB
SCHEMBL25122150 0.80 CRBN (0.51) CRBNDDB1HTTGAAPOLB
SCHEMBL25843786 0.79 CRBN (0.53) CRBNDDB1HTTGAAPOLB
SCHEMBL25122042 0.78 CRBN (0.59) CRBNDDB1HTTGAAPOLB
SCHEMBL25187957 0.78 CRBN (0.64) CRBNDDB1POLB
SCHEMBL19585871 0.78 CRBN (0.71) CRBNDDB1HTTGAAPOLB
SCHEMBL24125814 0.78 CRBN (0.64) CRBNDDB1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735438-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
EP-4735452-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
WO-2025006783-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS MERCK PATENT GMBH (DE) 2025-01-02 — — WO disclosed
WO-2025006753-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN MERCK PATENT GMBH (DE) 2025-01-02 — — WO disclosed
Send feedback